Jay Bradner, MD (Novartis Institutes for BioMedical Research), Aine Hanly, PhD (Amgen), Clifford Hudis, MD (American Society of Clinical Oncology), Constance Lehman, MD, PhD (Massachusetts General Hospital), and David Schenkein, MD (GV)
Moderated by Susan Hockfield, PhD (Koch Institute for Integrative Cancer Research at MIT)
